CDC Website CDC Website

To Join the NPIN community or

You are here


COVID-19: General Information | Testing | Vaccines |

Contact Organizations directly about changes to services or hours

HBV ECHO: Reducing Perinatal Transmission

Video developed through partnership with the Department of Health and Human Resources (HHS) Health Resources and Services Administration's (HRSA) Bureau of Primary Health Care, Project ECHO launched HBV ECHO, a national technical assistance program that helps enhance HRSA-funded health center capacity to reduce perinatal transmission of hepatitis B. Panelists discuss the teleECHO™ curriculum, challenges in addressing perinatal HBV in the primary care setting, and patient case studies.

School Health Policies and Practices (SHHPPS) website

This website contains the data and results from the SHHPPS, a national survey periodically conducted to assess school health policies and practices at the state, district, school, and classroom levels for 2016.

Organoid Modeling of Neural Stimulants and HIV Comorbidity of Human Brain (R01- Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) invites grant applications to study mechanisms underlying the neuropathophysiology of HIV-associated neurological disorders (HAND) using induced microglia and cerebral organoids generated from human derived induced pluripotent stem cell (iPSC) lines. Specific emphasis is on the comorbidity of HIV and neural stimulants, including methamphetamine, amphetamine, cocaine, and nicotine, studied at the single cell and neural circuits levels.

PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional)

NIDA is interested in research that addresses research gaps related to PrEP and its use among substance users, with the goals of improving PrEP management and implementation. Current US Public Health Service PrEP guidelines recommend PrEP for people who inject drugs (PWID) and mention alcohol and illicit drug use as potential concerns for clinical management. Only one clinical trial has evaluated PrEP among PWID and systematic data regarding the broader use of PrEP among substance users are limited.

Innovative Models for Delivering PrEP and STI Services to Stop HIV in the United States (R61/R33 Clinical Trial Optional)

he purpose of this FOA is encourage and support the development of effective strategies for expanding the provision of HIV pre-exposure prophylaxis (PrEP) in sexually transmitted infection (STI) service settings in high priority jurisdictions identified by the presidential initiative, Ending the HIV Epidemic: A Plan for America. Funding for the fourth and fifth years (s) will be dependent upon achieving negotiated go/no go criteria and milestones.

Adapting Immunotherapy and Gene Editing Based Strategies for Targeting HIV Reservoirs in the CNS: Potential Benefits and Risks (R21 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) invites research grant applications that propose studies for adapting immunotherapy and gene therapy-based strategies to target viral reservoirs in the central nervous system (CNS) and examine the potential risks of applying such technologies to the brain. Basic and translational research in domestic and international settings are of interest.

Consortium for Innovative HIV/AIDS Vaccine and Cure Research (UM1 Clinical Trial Not Allowed)

The purpose of this funding opportunity announcement (FOA) is to support consortia to conduct research toward the prevention and cure of HIV. The Consortium for Innovative HIV Vaccine and Cure Research will establish a collaborative and integrated research program built around two areas of scientific focus: identification of the correlates and the mechanism(s) of protection of preventive vaccine(s) and the use of vaccines or other immune modalities in advancing cure research.


Subscribe to RSS - Researchers